The Scottish Bioscreening Facility originated as a joint SULSA and Wellcome Trust funded initiative to stimulate collaborations and enable large siRNA and compound library screens. The SBF is based around High Content Image Based Screening (HCS) with the GE IN Cell 2000©. This wide-field fluorescence microscopy platform is useful for high throughput image capture and analysis of numerous parameters in a biologically relevant context.
Principal Disease Indication(s)
Small molecules, RNAi
HCI, HTS plate reader
Wellcome Trust, Scottish Universities Life Science Alliance (SULSA)
Number of Screens / year (any size):
Medicinal Chemistry Follow-up:
Phone: +44 (0)141 330 5300